View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
In association with Medidata
  1. Sponsored
November 5, 2021updated 03 Jan 2022 9:15am

Developing a unified approach to support the creation of new digital endpoints

Identifying the right sensors in support of hybrid or virtual trials is only the beginning. The ability to distill meaningful clinical insights from massive amounts of data requires a dynamic approach to data ingestion and analysis that will ultimately have the desired impact on the development of new digital endpoints. Join Medidata’s Ben Schlatka, VP of Digital Biomarker Solutions, as he discusses key considerations for developing a comprehensive data strategy to support the creation of new digital endpoints that impact safety monitoring, disease progression, and more effective treatments.

Speaker

Ben Schlatka VP, Digital Biomarker Solutions, Medidata

Free Webinar

Medidata: Developing a unified approach to support the creation of new digital endpoints

Download and watch the webinar

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena